Management of Low-Grade Gliomas: A Review of Patient-Perceived Quality of Life and Neurocognitive Outcome

Low-grade glioma (LGG) comprises nearly 20% of all central nervous system glial tumors, with approximately 2000−3000 patients diagnosed annually in the United States. Because of their infiltrative ability and aggressive nature, the average 10-year survival is 30% when

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World neurosurgery 2014-07, Vol.82 (1), p.e299-e309
Hauptverfasser:	Shields, Lisa B.E, Choucair, Ali K
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Brain Mapping Brain Neoplasms - psychology Brain Neoplasms - radiotherapy Brain Neoplasms - surgery Brain Neoplasms - therapy Brain tumor Cognition - physiology Cognitive function Combined Modality Therapy Glioma - psychology Glioma - radiotherapy Glioma - surgery Glioma - therapy Humans Immunotherapy Low-grade glioma Magnetic Resonance Imaging Neuropsychological Tests Neurosurgery Neurosurgical Procedures Prognosis Quality of Life Seizures Seizures - epidemiology Seizures - etiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Low-grade glioma (LGG) comprises nearly 20% of all central nervous system glial tumors, with approximately 2000−3000 patients diagnosed annually in the United States. Because of their infiltrative ability and aggressive nature, the average 10-year survival is 30% when
ISSN:	1878-8750 1878-8769
DOI:	10.1016/j.wneu.2014.02.033